The new HealthVerity: View from the Curisium CEO
Last week, HealthVerity announced its acquisition of Curisium, an innovator in cloud-based drug...
Rare diseases may be individually uncommon, but collectively they affect an estimated 30 million people in the United States. Yet for many patients, the path to diagnosis spans years, sometimes decades. Symptoms appear one at a time. Specialists...
Last week, HealthVerity announced its acquisition of Curisium, an innovator in cloud-based drug...
July 23, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity...
This week’s webinar, VBA 2.0 Building and accelerating VBA for the next era, offered a deeper look...
April 30, 2020 - Philadelphia, PA -HealthVerity announced the biweekly update to its HealthVerity...
July 9, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity...
Value-based agreements unite pharma companies and payers with a mutually beneficial payment model,...
Throughout the past quarter, we’ve announced major collaborations, built on existing partnerships...
June 25, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity...
June 11, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity...
May 28, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity...
Human papillomavirus (HPV) is one of the most common sexually transmitted infections in the United States. Almost all sexually active individuals are exposed to HPV at some point in their lifetime. Although most infections are asymptomatic and self-l...